Press release
Alzheimers Disease Therapeutics Market to Reap Excessive Revenues by 2020
View Report Preview @ https://www.persistencemarketresearch.com/market-research/alzheimers-disease-therapeutics-market.asp
North America dominates the global market for alzheimer’s disease therapeutics due to large number of aging population. Asia followed by the Europe are expected to show high growth rates in the next five years in the global alzheimer’s disease therapeutics market. China and India are expected to be the fastest growing alzheimer’s disease therapeutics markets in Asia-Pacific region. Some of the key driving forces for alzheimer’s disease therapeutics market in emerging countries are increasing R&D investment, large pool of patients and improvement of healthcare infrastructure.
In recent times there is increased in use of alzheimer’s disease therapeutics due to increasing prevalence of alzheimer’s disease. Increase geriatric population, increase in healthcare expenditure and increased government funding are some of the key factors driving the growth for the global alzheimer’s disease therapeutics market. In addition, increasing healthcare awareness and new diagnostic technologies for alzheimer’s disease are also fuelling the growth of the global alzheimer’s disease therapeutics market. However, strict regulations and long approval time for alzheimer’s disease therapeutics and expiry of several patent drugs are some of the major factors restraining the growth for the global alzheimer’s disease patient market.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/3401
Increasing R&D investment of biopharmaceutical companies would lead to growth in alzheimer’s disease therapeutics market in Asia. In addition, innovation of new drugs to treat, slow and prevent alzheimers disease and early diagnosis of alzheimers disease would develop opportunities for the global alzheimer’s disease therapeutics market.
Some of the major companies operating in the global alzheimer’s disease patient market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer, Inc., Novartis AG., Eisai Co., Ltd., Actavis, Daiichi Sankyo, Transtech Pharma and H. Lundbeck A/S.
Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/3401
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimers Disease Therapeutics Market to Reap Excessive Revenues by 2020 here
News-ID: 855558 • Views: …
More Releases from Persistence Market Research
Crates Market Is Expected to Reach US$ 8.7 Billion by 2033 - Persistence Market …
The global crates market plays a critical role in modern logistics, packaging, and supply chain operations across a wide range of industries. Crates are rigid containers designed to transport, store, and protect goods efficiently during handling, warehousing, and distribution. They are widely used in food and beverage, agriculture, pharmaceuticals, automotive, chemicals, and retail sectors due to their durability, stackability, and ability to support reusable and returnable packaging models. As supply…
Solar Power Mobile Devices Market Size to Reach US$ 12.7 Billion by 2033 - Persi …
The solar power mobile devices market is gaining rapid traction as consumers and industries increasingly seek portable, reliable, and sustainable power solutions. Solar powered mobile devices include smartphones, power banks, chargers, lighting systems, and communication equipment that integrate photovoltaic technology to generate electricity from sunlight. These devices are particularly valuable in off grid environments, emergency situations, outdoor activities, and regions with unreliable grid infrastructure.
Explore Full Report Quality - Free Sample…
Triethylene Glycol Market Size to Reach US$2.4 Billion by 2033 - Persistence Mar …
The global triethylene glycol market plays a crucial role across multiple industrial value chains, driven by its versatile chemical properties and wide applicability in energy, textiles, automotive, plastics, and consumer products. Triethylene glycol is a colorless, odorless, hygroscopic liquid known for its excellent moisture absorbing capability, low volatility, and relatively low toxicity compared to other glycols. These attributes make it a preferred choice in applications such as natural gas dehydration,…
Air Purifier Market Witnesses Strong Boom Amid Rising Air Quality Concerns
Introduction
The global air purifier market has gained significant traction in recent years as concerns over air quality, indoor pollution, and public health continue to intensify. Rapid urbanization, industrial expansion, rising vehicular emissions, and increasing awareness of respiratory health have positioned air purifiers as essential household and commercial appliances rather than luxury products. Air purifiers are designed to remove airborne contaminants such as dust, pollen, smoke, volatile organic compounds (VOCs), bacteria,…
More Releases for Alzheimer’s
Europe Alzheimer’s Drug Pipeline Analysis
The incidence of Alzheimer’s disease has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been observed that close to 50% of dependency of aged people in Europe is attributed for by Alzheimer’s disease. The rapid growth in the prevalence of Alzheimer's disease over the next few decades in Europe is expected to result in immense pressure…
Media Advisory: Alzheimer’s Disease Resource Center, Inc. Presents 10th Annual …
Who: Mary Ann Malack-Ragona, Executive Director/Chief Executive Officer, Alzheimer’s Disease Resource Center, Inc. (ADRC)
Participating Walk for Alzheimer’s teams and individuals
Mickey B, Radio Personality, WGBB Radio and Master of Ceremonies
Ronald McDonald
The Liberty Bells, USO troupe
What: Alzheimer’s Disease Resource Center, Inc. (ADRC) is presenting its 10th Annual Old Bethpage Walk for Alzheimer’s & Mexican Fiesta. There will be an opening ceremony with Mickey B, Radio Personality, WGBB Radio, as the Master of…
Home Care Assistance Partners with the Alzheimer’s Association to Promote Earl …
(Palo Alto, CA – November 29, 2011) Home Care Assistance, North America’s leading provider of in-home care for seniors, announced today that, along with companies including Genworth, Starbucks, Intel and Pfizer, they are now a Champion Partner of the Alzheimer’s Early Detection Alliance (AEDA). The AEDA is a program renowned for raising Alzheimer’s awareness and promoting early detection of the disease. As a member of this important alliance, Home…
Alzheimer’s Association Long Island Announces Release of Latest Report on Alzh …
Alzheimer’s Association Long Island announced the release of the most recent report about Alzheimer’s disease. “Alzheimer’s from the Frontlines: Challenges a National Alzheimer’s Plan Must Address” provides a look into the unrelenting challenges brought on by this disease by offering insights and perspectives from individuals across the country who participated in the Alzheimer’s Association’s public input process. The Association and over 70 of its chapters hosted 132 input sessions throughout…
Otava Alzheimer’s Disease Targeted Libraries
Alzheimer’s disease (AD) is a devastating and always fatal neurodegenerative disorder characterized by progressive impairment of cognitive function and emotional disturbances. Currently, more than 25 million people worldwide live with AD. But there is no cure for AD and no treatment to reverse its progression, there are medicines available that can help treat symptoms in some people with this disease. Intensive scientific research around the world brings us closer to…
Alzheimer’s Association Long Island Presents Public Input Session for National …
On August 24, Alzheimer’s Association Long Island will hold a public input session to solicit views, comments and perspectives from stakeholders in the Alzheimer’s community to assist in the development of a successful National Alzheimer’s Plan. The recommendations and comments expressed during these input sessions, taking place across the country in August, will be collected and shared this fall with officials from the U.S. Department of Health and Human Services,…
